Pharming.com

Home Pharming Group N.V.

WEBA global biopharmaceutical company developing and commercializing innovative protein replacement therapies and precision medicines to serve the unserved …

Actived: 5 days ago

URL: https://www.pharming.com/

About Us Pharming Group N.V.

WEBAbout Us. Pharming is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life threatening diseases. Pharming is …

Category:  Health Go Health

Pharming Group announces development plans for leniolisib for

WEBDisclaimer The information contained in the section of Pharming Group N.V.’s (the "Company") website that you are attempting to access is not intended for, …

Category:  Health Go Health

Pipeline Pharming Group N.V.

WEBPipeline. Pharming is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is …

Category:  Health Go Health

Associate Director, HEOR

WEBThe Associate Director, Health Economics and Outcomes Research (HEOR) will be responsible for a wide variety of matters in support of Pharming’s growth as we increase …

Category:  Health Go Health

Pharming Group reports financial results for full year 2020

WEBPharming Group N.V. presents its preliminary (unaudited) financial report for the full year ended 31 December 2020. Download full press releaseEN. Download …

Category:  Health Go Health

Deborah Jorn, MBA Pharming Group N.V.

WEBMs. Jorn was Executive Vice President of Corporate and Commercial Development at Eyepoint Pharmaceuticals from 2016 to 2018. Prior to joining Eyepoint, …

Category:  Health Go Health

JOENJA® (leniolisib) FDA Approval

WEBJoenja® ‒ looking ahead 7 Joenja® (leniolisib) is the first and only FDA-approved treatment for APDS Targeted treatment of APDS in patients aged 12 years and older

Category:  Health Go Health

Pharming Group N.V. announces the reimbursement of …

WEBDisclaimer The information contained in the section of Pharming Group N.V.’s (the "Company") website that you are attempting to access is not intended for, and must …

Category:  Health Go Health

Products Pharming Group N.V.

WEBThis product has been approved for use by the European Medicines Agency (EMA) in Europe, the Medicines & Healthcare products Regulatory Agency (MHRA) in the United …

Category:  Medicine Go Health

Pharming Announces Presentation of Positive Results of Phase III

WEBPharming announces that Principal Investigator V. Koneti Rao, MD, FRCPA, a staff physician in the Primary Immune Deficiency Clinic at the National Institutes of …

Category:  Health Go Health

Pharming announces the first commercial shipments of Joenja

WEBPharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S. Leiden, The Netherlands, April 11, 2023: Pharming Group N.V. (“Pharming”) …

Category:  Health Go Health

Pharming Announces Presentation of Positive Results of …

WEB3 . Pharming Group N.V. is a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the …

Category:  Medicine Go Health

9M 2022 Financial Results Analyst Call

WEB11. RUCONEST® sales of US$151.0 million for the first 9 months of 2022 Stable revenues. Will allocate resources to leniolisib with view of accelerating future growth Safe and …

Category:  Health Go Health

Pharming announces positive results of Phase II/III pivotal …

WEBLeniolisib is a small molecule PI3Kδ inhibitor that was discovered and developed by Novartis and was licensed to Pharming in 2019. The study, sponsored by Novartis, is a …

Category:  Health Go Health

Pharming Group Financial results full year 2021

WEBIn 2021, Pharming’s revenues decreased by 6% to US$198.9 million and operating profit decreased by 82% to US$13.6 million. Net profit decreased by 58% to US$16.0 million. …

Category:  Health Go Health

Pharming Group reports fourth quarter and full year 2023 …

WEB3 APDS patient finding ased on available literature, Pharming estimates APDS prevalence of 1.5 patients per million. Our U.S. and global APDS patient finding efforts progressed …

Category:  Health Go Health

Pharming Group reports second quarter and first half 2023 …

WEB4 Sale of Priority Review Voucher In June 2023, Pharming announced that it had entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher …

Category:  Health Go Health

Third quarter 2023 financial results

WEBJoenja® (leniolisib) is a prescription that is used to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) adults and pediatric patients 12 years. Joenja® …

Category:  Health Go Health

Group Financial Controller

WEBIntroduction: Pharming Group N.V. develops innovative protein therapeutics for the treatment of genetic disorders. The company is poised for further scientific, technological …

Category:  Health Go Health